|
08 Mar 2025
|
Others |
Inter-alia, to consider 1. Proposal for restructuring of the business of the Company. 2. Other business matters. |
|
06 Jan 2025
|
Quarterly Results |
- |
|
11 Nov 2024
|
Quarterly Results |
- |
|
12 Aug 2024
|
Quarterly Results |
- |
|
28 May 2024
|
Audited Results |
(Revised) |
|
31 Jan 2024
|
Quarterly Results |
- |
|
14 Nov 2023
|
Quarterly Results |
- |
|
14 Aug 2023
|
Quarterly Results |
- |
|
29 May 2023
|
Audited Results |
- |
|
31 Jan 2023
|
Quarterly Results |
- |
|
28 Oct 2022
|
Quarterly Results |
- |
|
10 Aug 2022
|
Quarterly Results & Others |
- |
|
19 May 2022
|
Audited & Quarterly Results |
- |
|
27 Jan 2022
|
Quarterly Results |
- |
|
12 Nov 2021
|
Quarterly Results |
- |
|
11 Aug 2021
|
Quarterly Results |
- |
|
29 Jun 2021
|
Audited Results |
- |
|
10 Mar 2021
|
Others |
Inter alia, to consider and approve the items as mentioned in the intimation of Board Meeting. |
|
13 Feb 2021
|
Quarterly Results |
- |
|
02 Dec 2020
|
A.G.M. |
Inter alia, to consider : 1. Appointment of Statutory Auditors to fill the casual vacancy. 2. To fix day, date, time and venue of the 24" Annual General Meeting. |
|
13 Nov 2020
|
Quarterly Results |
- |
|
14 Sep 2020
|
Quarterly Results |
- |
|
29 Jul 2020
|
Audited Results |
- |
|
30 Jun 2020
|
Audited Results |
- |
|
14 Feb 2020
|
Quarterly Results |
- |
|
14 Nov 2019
|
Quarterly Results |
- |
|
14 Aug 2019
|
Quarterly Results |
- |
|
14 Jun 2019
|
Others |
inter alia, Conversion of Warrants into Equity Shares - Promoters. |
|
28 May 2019
|
Audited Results |
- |
|
26 Mar 2019
|
Others |
inter alia, to consider conversion of warrants into Equity shares. |
|
11 Feb 2019
|
Quarterly Results |
- |
|
12 Nov 2018
|
Quarterly Results |
- |
|
27 Aug 2018
|
A.G.M. & ESOP |
- |
|
10 Aug 2018
|
Quarterly Results |
- |
|
30 May 2018
|
Audited Results |
- |
|
18 May 2018
|
Others |
- |
|
24 Jan 2018
|
Quarterly Results & Others |
- |
|
17 Nov 2017
|
Quarterly Results |
- |
|
23 Aug 2017
|
Quarterly Results |
- |
|
27 May 2017
|
Audited Results |
- |
|
14 Feb 2017
|
Quarterly Results & Others |
To raise funds for expansion of business and working capital requirements. |
|
27 Dec 2016
|
Others |
1. To consider the Shifting of Registered Office of the Company within the same city. 2. To consider the Reconstitution of various Sub Committees of the Board consequent upon change in directorship. |
|
14 Nov 2016
|
Quarterly Results |
- |
|
13 Oct 2016
|
Preferential Issue of shares |
- |
|
24 Aug 2016
|
Others |
To finalize acquisition of stake in a Company, which is engaged in Bio-technology and its related business. |
|
17 Aug 2016
|
Others |
The future business plans of the Company including the Acquisition of New Businesses or Entities by way of Equity/Investments in order to achieve inorganic growth. |
|
30 Jul 2016
|
Quarterly Results |
The Company has entered into the business of Sale of Wholesale Drugs and subsequently has obtained Drug License from Drugs Control Administration, Hyderabad, Government of Telangana. |
|
27 May 2016
|
Audited Results |
- |
|
13 Feb 2016
|
Quarterly Results & Others |
1. Appointment of Ms. Nishita Kalantri as Additional Director of the Company. 2. Resignation of Ms. Sripriya Mutgi from the post of Director. |
|
09 Nov 2015
|
Quarterly Results |
Appointment of Mr. Bonthu Pardhasara as Additional Director of the Company w.e.f. November 09, 2015. |